The activation of protein kinase C induces higher production of reactive oxygen species by mononuclear cells in patients with multiple sclerosis than in controls

Inflammation Research

Volumn 48, Issue 7, 1999, Pages 412-416

  Vladimirova, O ^a   Lu, F M ^a   Shawver, L ^a   Kalman, B ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Multiple sclerosis; Protein kinase C; Reactive oxygen species

Indexed keywords

CALPHOSTIN C; CYTOKINE; GAMMA INTERFERON; MITOCHONDRIAL DNA; PHORBOL ESTER; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; DNA DAMAGE; DOSE RESPONSE; ENZYME ACTIVATION; FEMALE; HAPLOTYPE; HUMAN; HUMAN CELL; MACROMOLECULE; MACROPHAGE; MALE; MONOCYTE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; RELAPSE; REMISSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROFLUOROMETRY; TARGET ORGAN; TISSUE DEGENERATION;

DNA, MITOCHONDRIAL; ENZYME ACTIVATION; HAPLOTYPES; HUMANS; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; MULTIPLE SCLEROSIS; PROTEIN KINASE C; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032806532     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050480     Document Type: Article

References (34)

1. Amstrong D, Al-Awadi F. Lipid peroxidation and retinopathy in streptozocin induced diabetes. Free Radic Biol Med 1991; 11: 433-6.
2. Bagasra O, Michaels FH, Zheng MY, Bobroski LE, Spitsin SV, Fu ZF, et al. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci USA 1995; 92: 12041-5.
3. Bo L, Dawson TM, Wesselingh S, Mork S, Choi S, Kong PA, et al. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 1994; 36: 778-86.
4. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, et al. Oxidative damage to DNA in diabetes mellitus. Lancet 1996; 347: 444-5.
5. Vachier I, Le Doucen C, Loubatiere J, Damon M, Terovanne B, Nicolas JC, et al. Imaging reactice oxygen species in asthma. J Biolumin Chemilumin 1994; 9: 171-5.
6. Richter C, Gogvadze V, Laffranchi R, Schlapbach R, Schweizer M, Suter M, et al. Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta 1995; 1271: 67-74.
7. Brett R, Rumsby MG. Evidence of free radical damage in the central nervous system of guinea-pigs at the prolonged acute and early relapse stages of chronic relapsing experimental allergic encephalomyelitis. Neurochem Int 1993; 23: 35-44.
8. MacMicking JD, Willenborg DO, Weidemann MJ, Rocket KA, Cowden WB. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: Enhancement by the soluble products of encephalitogenic T cells. J Exp Med 1992; 176: 303-7.
9. Ruuls SR, Bauer J, Sontrop K, Huitinga I, 't Hart BA, Dijkstra CD. Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol 1995; 56: 207-17.
10. Konat GW, Wiggins RC. Effect of reactive oxygen species on myelin membrane proteins. J Neurochem 1985; 45: 1113-8.
11. Bum YS, Kim SU. Oligodendroglial cell death induced by oxygen radicals and its protection by catalase. J Neurosci 1991; 29: 100-6.
12. Willenbourg DO, Bowern NA, Danta G, Doherty PC. Inhibition of allergic encephalomyelitis by the iron chelating agent desferrioxamine: an experimental model of multiple sclerosis. J Neuroimmunol 1988; 17: 127-35.
13. Fisher M, Levine PH, Weiner BH, Vaudreuil CH, Natale A, Johnson MH, et al. Monocyte and polymorphonuclear leukocyte toxic oxygen metabolite production in multiple sclerosis. Inflammation 1988; 12: 123-31.
14. Hammann KP, Hopf HC. Monocyte constitute the only peripheral blood cell population showing an increased burst activity in multiple sclerosis patients. Int Archs Allergy Appl Immun 1986; 81: 230-4.
15. Glabinski A, Tawsek NS, Bartosz G. Increased generation of superoxide radicals in the blood of MS patients. Acta Neurol Scand 1993; 88: 174-7.
16. Vladimirova O, O'Connor J, Cahill A, Alder H, Kalman B. Oxidative damage to DNA in plaques of MS brains. Mult Scler 1998; 4: 413-8.
17. Bruck W, Bitsch A, Kolenda H, Brack Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997; 42: 783-93.
18. Cross AH, Manning PT, Keeling RM, Schmidt RE, Misko TP. Peroxynitrite formation within the central nervous system in active multiple sclerosis. J Neuroimmunol 1998; 88: 45-56.
19. Powell T, Sussman JG, Davies-Jones GAB. MR imaging in acute multiple sclerosis: Ringlike appearance in plaques suggesting the presence of paramagnetic free radicals. Am J Neuroradiol 1992; 13: 1544-6.
20. Kalman B, Li S, Chatterjee D, O'Connor J, Voehl MR, Brown MD, et al. Large screening of the mitochondrial DNA reveals no pathogenic or polymorphic mutations but a haplotype associated with multiple sclerosis in Caucasians. Acta Neurol Scand 1999; 99: 16-25.
21. Kalman B, Alder H. Is the mitochondrial DNA involved in determining susceptibility to multiple sclerosis? [review]. Acta Neurol Scand 1998; 98: 232-7.
22. Rieckmann P, Albrecht M, Kitze B, Weber T, Tumani H, Broocks A, et al. Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann Neurol 1995; 37: 82-8.
23. Beck J, Rondot P, Catinot L, Falcoff E, Kirchner H, Wietzerbin J. Increased production of interferon-gamma and tumor necrosis precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand 1988; 78: 318-23.
24. Van Osten BW, Barkhof F, Scholten PET, von Blomberg BM, Ader JH, Polman CH. Increased production of tumor necrosis factor a, and not interferon γ, preceding disease activity in patients with multiple sclerosis. Arch Neurol 1998; 55: 793-8.
25. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
26. Rosenkranz AR, Schmaldienst S, Stuhlmeier KM, Chen W, Knapp W, Zlabinger GJ. A microplate assay for the detection of oxidative products using 2′,7′-dichlorofluorescin-diacetate. J Immunol Methods 1992; 156: 39-45
27. Tanabe T, Otani H, Mishima K, Ogawa R, Inagaki C. Phorbol 12-myristate 13-acetate (PMA) induced oxyradical production in rheumatoid synovial cells. Jpn J Pharmacol 1997; 73: 347-51.
28. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drovin J, et al. Sequence and organization of the human mitochondrial genome. Nature 1981; 290: 457-64.
29. Szamel M, Appel A, Schwinzer R, Resch K. Different protein kinase C isoenzymes regulate IL-2 receptor expression or IL-2 synthesis in human lymphocytes stimulated via the TCR. J Immunol 1998; 160: 2207-14.
30. Martino G, Brambilla E, Filippi M, et al. Interferon-γ activated calcium influx in peripheral blood lymphocytes from patients with primary and secondary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 1996; 61: 515-7.
31. Park JW, Babior BM. Activation of the leukocyte NADPH oxidase subunit p47phox by protein kinase C. A phosphorylation dependent change in conformation of the C-terminal end of p47phox. Biochemistry 1997; 36: 7474-80.
32. Lucas M, Sanches-Solino O, Solano F, Izquierdo G. Interferon-beta1b inhibits reactive oxygen species production in peripheral blood monocytes of patients with relapsing-remitting multiple sclerosis. Neurochem Int 1998; 33: 101-2.
33. Nagpala PG, Malik AB, Vuong PT, Lum H. Protein kinase C beta 1 overexpression augments phorbol ester-induced increase in endothelial permeability. J Cell Physiol 1996; 166: 249-55.
34. Pouly S, Storch MK, Matthieu JM, Lassmann H, Monnet-Tschudi F, Honegger P. Demyelination induced by protein kinase C-activating tumor promoters in aggregating brain cell cultures. J Neurosci Res 1997; 49: 121-32.